219 related articles for article (PubMed ID: 26481831)
21. Engineering the folding pathway of insect cells: generation of a stably transformed insect cell line showing improved folding of a recombinant membrane protein.
Lenhard T; Reiländer H
Biochem Biophys Res Commun; 1997 Sep; 238(3):823-30. PubMed ID: 9325175
[TBL] [Abstract][Full Text] [Related]
22. An actively mixed mini-bioreactor for protein production from suspended animal cells.
Diao J; Young L; Zhou P; Shuler ML
Biotechnol Bioeng; 2008 May; 100(1):72-81. PubMed ID: 18078290
[TBL] [Abstract][Full Text] [Related]
23. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
[TBL] [Abstract][Full Text] [Related]
24. A novel oscillating bioreactor BelloCell: implications for insect cell culture and recombinant protein production.
Lu JT; Chung YC; Chan ZR; Hu YC
Biotechnol Lett; 2005 Aug; 27(15):1059-65. PubMed ID: 16132854
[TBL] [Abstract][Full Text] [Related]
25. Scalable inoculation strategies for microcarrier-based animal cell bioprocesses.
Dürrschmid M; Landauer K; Simic G; Blüml G; Doblhoff-Dier O
Biotechnol Bioeng; 2003 Sep; 83(6):681-6. PubMed ID: 12889032
[TBL] [Abstract][Full Text] [Related]
26. Effects of oxygen on recombinant protein production by suspension cultures of Spodoptera frugiperda (Sf-9) insect cells.
Scott RI; Blanchard JH; Ferguson CH
Enzyme Microb Technol; 1992 Oct; 14(10):798-804. PubMed ID: 1369406
[TBL] [Abstract][Full Text] [Related]
27. Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor.
Valkama AJ; Leinonen HM; Lipponen EM; Turkki V; Malinen J; Heikura T; Ylä-Herttuala S; Lesch HP
Gene Ther; 2018 Jan; 25(1):39-46. PubMed ID: 29345252
[TBL] [Abstract][Full Text] [Related]
28. Growth, metabolic activity, and productivity of immobilized and freely suspended CHO cells in perfusion culture.
Hilal-Alnaqbi A; Hu AY; Zhang Z; Al-Rubeai M
Biotechnol Appl Biochem; 2013; 60(4):436-45. PubMed ID: 23701045
[TBL] [Abstract][Full Text] [Related]
29. Purification of rabies virus glycoprotein produced in Drosophila melanogaster S2 cells: An efficient immunoaffinity method.
Pilatti L; Mancini Astray R; Rocca MP; Barbosa FF; Jorge SAC; Butler M; de Fátima Pires Augusto E
Biotechnol Prog; 2020 Nov; 36(6):e3046. PubMed ID: 32628317
[TBL] [Abstract][Full Text] [Related]
30. Bioprocess parameters of cell growth and human mu opioid receptor expression in recombinant Drosophila S2 cell cultures in a bioreactor.
Brillet K; da Conceição MM; Pattus F; Pereira CA
Bioprocess Biosyst Eng; 2006 Apr; 28(5):291-3. PubMed ID: 16333670
[TBL] [Abstract][Full Text] [Related]
31. Rabies virus glycoprotein and immune response pattern using recombinant protein or recombinant RNA viral vectors.
Astray RM; Ventini DC; Boldorini VL; Silva FG; Rocca MP; Pereira CA
Vaccine; 2014 May; 32(24):2829-32. PubMed ID: 24598721
[TBL] [Abstract][Full Text] [Related]
32. Bioreactor systems for the production of biopharmaceuticals from animal cells.
Warnock JN; Al-Rubeai M
Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
[TBL] [Abstract][Full Text] [Related]
33. A novel control scheme for inducing angiostatin-human IgG fusion protein production using recombinant CHO cells in a oscillating bioreactor.
Wang IK; Hsieh SY; Chang KM; Wang YC; Chu A; Shaw SY; Ou JJ; Ho L
J Biotechnol; 2006 Feb; 121(3):418-28. PubMed ID: 16162365
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the Single-Use Fixed-Bed Bioreactors in Scalable Virus Production.
Lesch HP; Valonen P; Karhinen M
Biotechnol J; 2021 Jan; 16(1):e2000020. PubMed ID: 32971565
[TBL] [Abstract][Full Text] [Related]
35. Scale-up of virus-like particles production: effects of sparging, agitation and bioreactor scale on cell growth, infection kinetics and productivity.
Maranga L; Cunha A; Clemente J; Cruz P; Carrondo MJ
J Biotechnol; 2004 Jan; 107(1):55-64. PubMed ID: 14687971
[TBL] [Abstract][Full Text] [Related]
36. Assessment of packed bed bioreactor systems in the production of viral vaccines.
Rajendran R; Lingala R; Vuppu SK; Bandi BO; Manickam E; Macherla SR; Dubois S; Havelange N; Maithal K
AMB Express; 2014; 4():25. PubMed ID: 24949260
[TBL] [Abstract][Full Text] [Related]
37. Study of kinetic parameters for the production of recombinant rabies virus glycoprotein.
Mendonça RZ; Greco KN; Moraes RH; Astray RM; Barral M
Cytotechnology; 2009 Jul; 60(1-3):143-51. PubMed ID: 19842054
[TBL] [Abstract][Full Text] [Related]
38. Tubular Bioreactor for Probing Baculovirus Infection and Protein Production.
Wu HC; Hu YC; Bentley WE
Methods Mol Biol; 2016; 1350():461-7. PubMed ID: 26820873
[TBL] [Abstract][Full Text] [Related]
39. Monoterpenoid oxindole alkaloid production by Uncaria tomentosa (Willd) D.C. cell suspension cultures in a stirred tank bioreactor.
Trejo-Tapia G; Cerda-García-Rojas CM; Rodríguez-Monroy M; Ramos-Valdivia AC
Biotechnol Prog; 2005; 21(3):786-92. PubMed ID: 15932257
[TBL] [Abstract][Full Text] [Related]
40. Rabies virus glycoprotein expression in Drosophila S2 cells. I: design of expression/selection vectors, subpopulations selection and influence of sodium butyrate and culture medium on protein expression.
Lemos MA; Santos AS; Astray RM; Pereira CA; Jorge SA
J Biotechnol; 2009 Aug; 143(2):103-10. PubMed ID: 19615415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
